Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/10/2014 | US8748390 Immunogenic epitopes of NGEP antigen |
06/10/2014 | US8748389 Treating cancer |
06/10/2014 | US8748388 Antitumoral compounds |
06/10/2014 | US8748387 Methods for treating pain |
06/10/2014 | US8748386 Immunological targeting of pathological Tau proteins |
06/10/2014 | US8748385 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes |
06/10/2014 | US8748383 Method for treating bone related diseases and calcium disorders |
06/10/2014 | US8748382 Method of drug delivery for bone anabolic protein |
06/10/2014 | US8748381 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
06/10/2014 | US8748380 Albumin variants |
06/10/2014 | US8748379 RTEF-1 variants and the use thereof for inhibition of angiogenesis |
06/10/2014 | US8748378 Therapies for acute renal failure |
06/10/2014 | US8748377 Pharmaceutical compositions |
06/10/2014 | US8748376 Stable formulations of peptides |
06/10/2014 | US8748375 Methods for affecting body composition using amylin agonists |
06/10/2014 | US8748374 Macrocyclic hepatitis C serine protease inhibitors |
06/10/2014 | US8748373 Hepatitis B virus compositions and methods of use |
06/10/2014 | US8748371 Nuclear targeting sequences |
06/10/2014 | US8748370 Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation |
06/10/2014 | US8748369 Use of targeted nitroxide agents in bone healing |
06/10/2014 | US8748368 Methods for preserving organs and tissues |
06/10/2014 | US8748367 Use of antisecretory factor |
06/10/2014 | US8748169 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
06/10/2014 | US8748151 Clostridial neurotoxins with altered persistency |
06/10/2014 | US8748105 Method for selecting a candidate drug compound |
06/10/2014 | US8747924 Methods for preventing and treating neurodegenerative diseases |
06/10/2014 | US8747906 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
06/10/2014 | US8747886 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications |
06/10/2014 | US8747865 Use of botulinum neurotoxin to alleviate various disorders |
06/10/2014 | US8747864 Staphylococcus aureus proteins and nucleic acids |
06/10/2014 | US8747848 Immunoglobulins with reduced aggregation |
06/10/2014 | US8747842 Pharmacological vitreolysis |
06/10/2014 | US8747841 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury |
06/10/2014 | US8747840 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities |
06/10/2014 | US8747833 B7-H1 and methods of diagnosis, prognosis, and treatment of cancer |
06/10/2014 | US8747829 Presbyopia treatment by lens alteration of disulfide bonds and reduction |
06/10/2014 | US8747808 Radiolabeled annexins |
06/10/2014 | US8747467 Muscle-based grafts/implants |
06/10/2014 | CA2681551C Prophylactic agent for renal failure |
06/10/2014 | CA2562871C Iron based compounds for elastogenesis and connective tissue treatment |
06/10/2014 | CA2554683C Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers |
06/10/2014 | CA2507373C Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
06/10/2014 | CA2482810C Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
06/10/2014 | CA2482634C Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction |
06/10/2014 | CA2459816C Hybrid and tandem expression of neisserial proteins |
06/10/2014 | CA2457322C Process for the maturation of dentritic cells and a vaccine |
06/10/2014 | CA2441287C Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
06/10/2014 | CA2399280C Defects in periaxin associated with myelinopathies |
06/10/2014 | CA2326598C Fusion proteins of mycobacterium tuberculosis antigens and their uses |
06/05/2014 | WO2014085674A1 Method for synchronizing time of insemination in gilts |
06/05/2014 | WO2014085637A1 New lantibiotic derivatives and a process for their preparation |
06/05/2014 | WO2014085621A1 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof |
06/05/2014 | WO2014085616A1 Computationally optimized broadly reactive antigens for h1n1 influenza |
06/05/2014 | WO2014085579A1 Copolymers for the delivery of drugs into cells |
06/05/2014 | WO2014085576A1 Synergistic combinations of fungicides and physical membrane disrupting agents and methods of use |
06/05/2014 | WO2014085419A1 Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species |
06/05/2014 | WO2014085349A1 Lyophilized formulation of tat-nr2b9c |
06/05/2014 | WO2014085154A1 Methods for treating renal disease |
06/05/2014 | WO2014084456A1 Composition comprising recombinant fusion protein of pathogenic antigen protein and flagellin of vibrio vulnificus for preventing, alleviating, or treating aging |
06/05/2014 | WO2014084378A1 Anticancer drug comprising cyclic rgd sequence-containing peptide |
06/05/2014 | WO2014084027A1 Medical uses of cell membrane-permeable fibroblast growth factor |
06/05/2014 | WO2014083578A1 A process for the preparation of solomonamide analogues |
06/05/2014 | WO2014083233A1 Microparticles with egf, method of preparation and use |
06/05/2014 | WO2014083058A1 Combination therapy with volasertib |
06/05/2014 | WO2014083040A2 Progranulin as marker for autoimmune disorders |
06/05/2014 | WO2014082773A1 Use of microorganisms for reducing the level of trimethylamine in a human body cavity, in particular for the treatment of trimethylaminuria or of bacterial vaginosis and the prevention of cardiovascular diseases |
06/05/2014 | WO2014052693A3 Veterinary composition and methods for non-surgical neutering and castration |
06/05/2014 | WO2014041483A3 Methods for producing recombinant factor viii chains from non-filamentous fungi, their functional reconstitution and applications thereof |
06/05/2014 | WO2014026054A3 CD20 scFv-ELPs METHODS AND THERAPEUTICS |
06/05/2014 | WO2007141778A3 Development of follicle stimulating hormone agonists and antagonists in fish |
06/05/2014 | US20140155835 Leuprolide injection |
06/05/2014 | US20140155816 Method for treating brain injury or stroke |
06/05/2014 | US20140155496 Templated Native Silk Smectic Gels |
06/05/2014 | US20140155470 Pla2r1 as anti-tumoral compound and as biomarker for the detection of cancer |
06/05/2014 | US20140155332 Selective inhibitors of tumor-initiating cells |
06/05/2014 | US20140155331 Novel high affinity bivalent helically constrained peptide against cancer |
06/05/2014 | US20140155327 Process for the Synchronization of Ovulation for Timed Breeding Without Heat Detection |
06/05/2014 | US20140155326 Egfr and c-met fibronectin type iii domain binding molecules |
06/05/2014 | US20140155325 Egfr and c-met fibronectin type iii domain binding molecules |
06/05/2014 | US20140155322 Method of Preventing Or Reducing Scarring Of Human Skin |
06/05/2014 | US20140155321 Polypeptides and Their Use |
06/05/2014 | US20140155320 Use of storage stable viscous phospholipid depot to treat wounds |
06/05/2014 | US20140155316 Fibroblast growth factor 1 protein fragments and methods of use |
06/05/2014 | US20140155315 Synthetic linear apelin mimetics for the treatment of heart failure |
06/05/2014 | US20140155314 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion |
06/05/2014 | US20140155313 Hydrogels with covalently linked polypeptides |
06/05/2014 | US20140155288 Methods for diagnosing cancer |
06/05/2014 | US20140154797 Lysis/Resealing Process and Device for Incorporating an Active Ingredient, in Particular Asparaginase or Inositol Hexaphosphate, in Erythrocytes |
06/05/2014 | US20140154781 Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy |
06/05/2014 | US20140154738 Protein glycosylation modification in methylotrophic yeast |
06/05/2014 | US20140154340 Methods to treat cancer using cyclosporine and cyclosporine derivatives |
06/05/2014 | US20140154304 Combination therapy with volasertib |
06/05/2014 | US20140154302 Antimicrobial compositions for treating microbial infections |
06/05/2014 | US20140154300 Methods and compositions for treatment of lesioned sites of body vessels |
06/05/2014 | US20140154277 Pharmaceutical Compositions Comprising Soluble CD137 |
06/05/2014 | US20140154272 Compound and method for modulating opioid receptor activity |
06/05/2014 | US20140154267 Use of interleukin-4 antagonists and compositions thereof |
06/05/2014 | US20140154260 B-7 related nucleic acids and polypeptides useful for immunomodulation |
06/05/2014 | US20140154237 Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositions |
06/05/2014 | US20140154235 Wound debridement compositions containing seaprose and methods of wound treatment using same |